Compare Goodyear Indonesia Tbk. (GDYR) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Goodyear Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Goodyear Indonesia Tbk. trades at Rp1,130 (market cap 457.15B, 2.4K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Goodyear Indonesia Tbk. is far larger — about 4.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| GDYR | SCPI | |
|---|---|---|
Market Cap | 457.15B | 104.4B |
Volume | 2.4K | — |
Lot | 24 | — |
Turnover | 2.7M | — |
Average Price | 1,124.79 | — |
Value | 2.7M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Goodyear Indonesia Tbk.
PT Goodyear Indonesia Tbk (the Company) was established on January 6, 1917 under the name “NV The Goodyear Tire & Rubber Company Limited” and changed its name to “PT Goodyear Indonesia” on July 25, 1978. On November 10, 1980, the Company obtained approval from the Capital Market Supervisory Board (BAPEPAM) to offer a portion of its shares to the public through the Indonesia Stock Exchange. Effective December 22, 1980, 6,150,000 shares of the Company with total par value of Rp 6,150,000 (equivalent to 15% of the total issued and outstanding shares) were officially listed in Jakarta Stock Exchange.
Read more on GDYR →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
